Table 3.

Performance of prognostic models for five-year overall survival in colorectal cancer patients when including and excluding tumor F. nucleatum status

	AUROC (95% CI)
Tumor stage	0.68 (0.60–0.76)
Tumor stage + F. nucleatum	0.69 (0.61–0.77)
Age, sex, tumor stage	0.78 (0.72–0.85)
Age, sex, tumor stage + F. nucleatum	0.78 (0.71–0.85)
Age, sex, tumor stage, treatment	0.78 (0.71–0.84)
Age, sex, tumor stage, treatment + F. nucleatum	0.78 (0.71–0.84)
Age, sex, tumor stage, treatment, and MSI status	0.83 (0.77–0.89)
Age, sex, tumor stage, treatment, and MSI status + F. nucleatum	0.83 (0.77–0.89)

F. nucleatum, Fusobacterium nucleatum; AUROC, area under receiver operating characteristic curve, 95% CI, 95% confidence intervals; MSI, microsatellite instability